Ajibio-Pharma-Services is a globally recognized Contract Development and Manufacturing Organization (CDMO) dedicated to supporting the biotechnology and pharmaceutical industries. They provide a wide range of services, including cGMP manufacturing of Active Pharmaceutical Ingredients (APIs) for small and large molecules, drug product fill and finish services, oligonucleotide synthesis, and high-potency APIs (HPAPI). With a strong focus on quality, reliability, and innovation, Ajibio-Pharma-Services helps clients advance their therapeutic programs from preclinical development through to commercial supply.
Serves as a key operational hub for North American CDMO services, including process development, large and small molecule manufacturing, aseptic fill & finish, and quality control for biopharmaceuticals.
State-of-the-art cGMP manufacturing suites, advanced analytical laboratories, multi-purpose fill/finish lines including capacity for high-value drug products, and facilities designed for handling high-potency compounds.
A collaborative, science-driven, and customer-centric environment focused on quality, precision, and innovation in pharmaceutical development and manufacturing. Emphasis on continuous improvement and adherence to stringent global regulatory standards.
The San Diego headquarters is strategically located in a prominent US biotech cluster, facilitating talent acquisition, industry collaboration, and efficient service to North American clients. It plays a crucial role in the company's global service delivery network.
Ajibio-Pharma-Services supports pharmaceutical and biotech clients globally through its network of manufacturing sites and offices in North America (USA), Europe (Belgium, Switzerland), and Asia (Japan). Functions supported globally include: cGMP manufacturing of small and large molecule Active Pharmaceutical Ingredients (APIs), custom synthesis of oligonucleotides (AJIPHASE®), aseptic fill & finish of drug products, process development and optimization, analytical method development and validation, quality control and assurance, regulatory support, and integrated supply chain management for both clinical and commercial stage therapeutics.
11040 Roselle Street
San Diego
CA
USA
Address: c/o Lonza AG, Rottenstrasse 6, Lonzastrasse, 3930 Visp, Switzerland
Serves as a key European hub for sterile drug product manufacturing, supporting clients with clinical and commercial supply needs in Europe and globally, particularly for complex biologics.
Address: Industrieweg 22 - Zone C, 9230 Wetteren, Belgium (S.A. AJINOMOTO OMNICHEM N.V.)
A critical European center for small molecule API development and manufacturing, providing comprehensive services from early clinical stages through commercial supply to global pharmaceutical clients.
Address: 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-8681, Japan (within Ajinomoto Co., Inc. facilities)
Serves as a center of excellence for advanced oligonucleotide synthesis and R&D in the Asia-Pacific region, supporting the development of nucleic acid-based therapeutics for global markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ajinomoto Bio-Pharma Services' leadership includes:
Ajinomoto Bio-Pharma Services has been backed by several prominent investors over the years, including:
In the past 12-18 months, Ajibio-Pharma-Services has seen key leadership appointments, including a new General Manager for the global Bio-Pharma Services Department and a new President & CEO for its US operations, signaling a focus on continued growth and strategic direction.
Discover the tools Ajinomoto Bio-Pharma Services uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Email formats for Ajinomoto Bio-Pharma Services typically follow standard corporate structures, often using a combination of first name and last name. For US operations, the domain @us.ajibio-pharma.com is common. Other regional or global communications might use @ajibio-pharma.com or @ajinomoto.com depending on the specific entity and role.
first.last@us.ajibio-pharma.com
Format
jane.doe@us.ajibio-pharma.com
Example
80%
Success rate
Business Wire • March 26, 2024
Ajinomoto Bio-Pharma Services announced a significant expansion of its fill finish capabilities at its San Diego, CA facility with the addition of a new high-speed, multi-purpose filling line. This investment aims to meet growing demand for sterile drug product manufacturing and enhance flexibility for client projects....more
PR Newswire • November 2, 2023
Ajinomoto Bio-Pharma Services announced the appointment of Tatsuya Okuzumi as President and CEO of its US operations, effective October 1, 2023. Okuzumi brings extensive experience from various leadership roles within Ajinomoto Co., Inc. and is poised to lead the company's growth in the US market....more
Contract Pharma • September 19, 2023
Ajinomoto Bio-Pharma Services detailed enhancements to its AJIPHASE® oligonucleotide synthesis and supply platform, including increased manufacturing capacity and technological advancements. These improvements are designed to support the rapidly growing market for nucleic acid therapies and provide robust solutions for its clients....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ajinomoto Bio-Pharma Services, are just a search away.